Author

Amy L. Lu

University of Virginia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Charles Edward ChalfantiD· 2 shared H. Patrick MacKnightiD· 2 shared Xiujie XieiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Charles Edward ChalfantORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The long non-coding RNA, CyKILRb, augments oncogenic phenotypes via induction of PIK3R2 and activation of the PI3K/AKT axis

Xiujie Xie, H. Patrick MacKnight, Amy L. Lu, Charles Edward Chalfant

This study identifies CyKILRb as an oncogenic long non-coding RNA that promotes tumorigenesis by upregulating PIK3R2 and activating the PI3K/AKT pathway.

bioRxiv · Oct 13, 2025 · PreprintCancer Biology

RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small cell lung cancer

Xiujie Xie, H. Patrick MacKnight, Amy L. Lu, Charles Edward Chalfant

The paper identifies a long non-coding RNA, CyKILR, with two splice variants that have opposing effects on tumor growth and cell survival in NSCLC.

Molecular Therapy — Nucleic Acids · Dec 5, 2024Peer-reviewedMolecular Biology